Luna Diabetes Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $23.6M

  • Investors
  • 7

Luna Diabetes General Information

Description

Manufacturer of an automated insulin delivery system designed for overnight use by insulin pen users. The company's platform delivers micro-boluses during sleep without a traditional pump, enabling users to stabilize nighttime glucose, reduce sleep disruptions, and improve daily blood sugar control through a simple, non-intrusive device.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1815 West 13th Street
  • Suite 5
  • Wilmington, DE 19806
  • United States
+1 (650)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 1815 West 13th Street
  • Suite 5
  • Wilmington, DE 19806
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luna Diabetes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 12-Aug-2025 $23.6M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Luna Diabetes’s complete valuation and funding history, request access »

Luna Diabetes Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1 12,390,624 $0.000100 8% $0.89 $0.89 1x $0.89 24.13%
To view Luna Diabetes’s complete cap table history, request access »

Luna Diabetes Patents

Luna Diabetes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250135109-A1 Medication fluid delivery device component and method of use Pending 26-Oct-2023
AU-2024367589-A1 Medication fluid delivery device component with filling interface Pending 26-Oct-2023
EP-4798270-A1 Medication fluid delivery device component with filling interface Pending 26-Oct-2023
WO-2025088557-A1 Medication fluid delivery device component with filling interface Inactive 26-Oct-2023
EP-4511839-A1 Insulin management for delivering insulin during a fasting period Pending 18-Apr-2022 A61M5/1723
To view Luna Diabetes’s complete patent history, request access »

Luna Diabetes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Luna Diabetes Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
2468 Ventures Venture Capital Minority
Ascensia Diabetes Care Corporation Minority
Interlock Capital Venture Capital Minority
Serpentine Ventures Venture Capital Minority
Vensana Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Luna Diabetes FAQs

  • When was Luna Diabetes founded?

    Luna Diabetes was founded in 2020.

  • Where is Luna Diabetes headquartered?

    Luna Diabetes is headquartered in Wilmington, DE.

  • What is the size of Luna Diabetes?

    Luna Diabetes has 8 total employees.

  • What industry is Luna Diabetes in?

    Luna Diabetes’s primary industry is Other Healthcare Technology Systems.

  • Is Luna Diabetes a private or public company?

    Luna Diabetes is a Private company.

  • What is the current valuation of Luna Diabetes?

    The current valuation of Luna Diabetes is .

  • What is Luna Diabetes’s current revenue?

    The current revenue for Luna Diabetes is .

  • How much funding has Luna Diabetes raised over time?

    Luna Diabetes has raised $23.6M.

  • Who are Luna Diabetes’s investors?

    2468 Ventures, Ascensia Diabetes Care, Interlock Capital, Serpentine Ventures, and Vensana Capital are 5 of 7 investors who have invested in Luna Diabetes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process